𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Double Click Reaction for the Acquisition of a Highly Potent and Selective mPTPB Inhibitor

✍ Scribed by Dr. Rongjun He; Dr. Zhihong Yu; Dr. Yantao He; Dr. Li-Fan Zeng; Dr. Jie Xu; Li Wu; Andrea M. Gunawan; Lina Wang; Dr. Zhong-Xing Jiang; Prof. Dr. Zhong-Yin Zhang


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
449 KB
Volume
5
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is a major worldwide threat to public health. Mycobacterium protein tyrosine phosphatase B (mPTPB) is a virulent phosphatase secreted by Mtb, which is essential for the survival and persistence of the bacterium in the host. Consequently, small‐molecule inhibitors of mPTPB are expected to serve as anti‐TB agents with a novel mode of action. Herein, we report the discovery of highly potent and selective mPTPB inhibitors using a novel, double Click chemistry strategy. The most potent mPTPB inhibitor from this approach possesses a K~i~ value of 160 nM and a >25‐fold selectivity for mPTPB over 19 other protein tyrosine phosphatases (PTBs). Molecular docking study of the enzyme–inhibitor complex provides a rationale for the high potency and selectivity of the lead compound and reveals an unusual binding mode, which may guide further optimization effort.


📜 SIMILAR VOLUMES


The syntheses and in vitro biotransforma
✍ Brad D. Maxwell; Scott B. Tran; Shiang-Yuan Chen; Donglu Zhang; Bang-Chi Chen; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 223 KB 👁 1 views

## Abstract Apixaban is a potent inhibitor of blood coagulation Factor Xa in the late stages of development. [^14^C]apixaban was synthesized with the 14C label in the two different lactam ring systems within the molecule for various __in vitro__ and __in vivo__ metabolism studies. A nine‐step synth